Data from Lifecare’s Clinical Development Study LFC-SEN-001 confirm that the Company’s Continuous Glucose Monitoring (CGM) system (Sencell) has a solid clinical accuracy: the mean average of absolute error (MARD) between Sencell and matched relative reference values was 9,6%. In context, regulatory authorities expect a MARD below 10% to acknowledge CGM for therapeutic (medical) decisions […]
Read more